Dr. Reddy's gets EIR for API manufacturing facility in Andhra Pradesh

06 Sep 2024 Evaluate

Dr. Reddy's Laboratories has received the Establishment Inspection Report (EIR) for API manufacturing facility (CTO-6) in Srikakulam, Andhra Pradesh. Earlier, the inspection was conducted by the United States Food & Drug Administration (USFDA) at this facility.

The USFDA has classified the inspection as Voluntary Action Indicated (VAI) and concluded that the inspection is ‘closed’ under 21 CFR 20.64(d)(3). 

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.


Dr. Reddys Lab Share Price

1213.90 19.35 (1.62%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.